Treatment Outcomes and Quality-of-Life Issues for Patients Treated With Prostate Brachytherapy

Laurie J. Abel

Jane Dafoe-Lambie

Wayne M. Butler

Gregory S. Merrick

prostatic neoplasms, radioisotope brachytherapy, quality of life
CJON 2003, 7(1), 48-54. DOI: 10.1188/03.CJON.48-54

The increasing popularity of brachytherapy for treatment of early-stage prostate cancer requires oncology nurses to have a comprehensive knowledge of the disease, its treatment, and management of side effects. Because quality-of-life (QOL) issues have become an important consideration in treatment selection for many patients, oncology nurses must have a thorough understanding of these QOL issues and their management. Armed with knowledge about prostate brachytherapy and its effect on QOL, oncology nurses can offer accurate information and evidence-based symptom management techniques to patients undergoing brachytherapy for prostate cancer.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.